André León discusses his experience studying influenza coast to coast. Follow his journey to New York City for virology training in the Krammer lab!
Dr. Kathleen Neuzil leaves the University of Maryland to serve as the Director of NIH’s Fogarty International Center and Dr. Justin Ortiz assumes the role of PI of the UMB CIVICs Clinical Core.
World-renowned influenza immunity and vaccine development expert, Florian Krammer, Ph.D., has assumed a new role as Professor of Infection Medicine at the University of Vienna.
CIVR-HRP researchers found that live attenuated versus inactivated influenza vaccines differ in the quality and quantity of immune responses.
Dr. Kevin McCarthy discusses his experience completing a project through the Fall 2023 cycle of the CIVICs Collaborative Training Program.
The Duke CIVIC Vaccine Center (DCVC) hosted a hybrid annual retreat on May 4 and 5, the second retreat since the contract’s inception in September
The National Institute of Allergy and Infectious Diseases (NIAID) announced that the Duke Human Vaccine Institute (DHVI) has initiated enrollment of volunteers for a clinical
Florian Krammer, Principal Investigator of SEM-CIVIC, was elected to the 2023 Fellowship Class for the American Academy of Microbiology for his significant contributions to the field of microbiology.
The Pharmaceutical Society of Japan awarded Dr. Kristy Ainslie, of CIVR-HRP, the 2023 Sato Memorial International Award for her notable achievements in the field of pharmaceutical sciences.
Researchers from Duke CIVIC Vaccine Center (DCVC) developed an mRNA-lipid nanoparticle vaccine incorporating hemagglutinin antigens from 20 different influenza subtypes.